Ban on Government Contracts with Biotechnology Companies Posing National Security Risks.
This legislation prohibits US Executive agencies from contracting with or using biotechnology equipment and services provided by companies identified as national security concerns, often linked to foreign adversaries. The goal is to safeguard sensitive government data and supply chains, ensuring taxpayer money does not fund these entities. The ban takes effect 180 days after enactment, with specific exceptions for overseas healthcare services.
Key points
Federal agencies are barred from procuring or renewing contracts for equipment and services from designated 'biotechnology companies of concern' (e.g., BGI Group, MGI Group).
The law aims to enhance national security by preventing taxpayer funds, including loan and grant funds, from supporting entities controlled by foreign adversaries.
Exceptions allow for continued provision of essential services, such as healthcare for US personnel stationed overseas, and the use of commercially available genetic sequencing data.
Expired
Citizen Poll